Chewy, Inc.

NYSE:CHWY

Specialty Retail

Consumer Cyclical
$20.70 -0.45%

-$0.08 today

Market cap
$8.32B
Beta
1.43
P/E (TTM)
36.7
EPS (TTM)
$0.48
52W Low $17.65High $43.84

Volume 6.32M

Average 10.76M

CHWY Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Chewy, Inc.NYSE: CHWY

Research & Development · Q2 FY2026 · quarter ended Aug 2026

Research & development remains negative

Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterAug 2026
$0— QoQ
Last fiscal yearFeb 2026
$0— YoY
LTMAug 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How CHWY compares with its peers on the latest reported figures

  • CHWY's LTM Aug 2026 research & development of $0 is the highest of the 4 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for CHWY, versus a peer median of 0.0%.
CHWY Competitors Peer median
Research & Development for CHWY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CHWYChewy, Inc.LTM Aug 2026$0 ——0.0%
FRPTFreshpet, Inc.LTM Sep 2026$0 ——0.0%
WOOFPetco Health and Wellness Company, Inc.LTM May 2026$0 ——0.0%
BARKBARK, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding CHWY) $0——0.0%

Competitors are the stored peer set for CHWY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jan 2022
FY2022
Jan 2023
FY2023
Jan 2024
FY2024
Feb 2025
FY2025
Feb 2026
Revenue8.97B10.12B11.15B11.86B12.6B
Cost of Revenue6.58B7.28B7.99B8.39B8.85B
Gross Profit2.39B2.83B3.16B3.47B3.75B
Gross Margin26.6%28.0%28.4%29.2%29.8%
Research & Development00000
Selling, General & Admin2.46B2.78B3.19B3.36B3.5B
Operating Expenses2.46B2.78B3.19B3.36B3.5B
Depreciation & Amortization55.32M83.44M109.69M114.56M129.3M
EBITDA(17.72M)138.56M161.51M271.77M397.2M
EBITDA Margin-0.2%1.4%1.4%2.3%3.2%
Operating Income(73.57M)56.42M(23.63M)112.59M254.3M
Operating Margin-0.8%0.6%-0.2%0.9%2.0%
Interest Income523K11.87M62.08M40.59M19.8M
Interest Expense2.16M2.58M3.58M5.52M4.6M
Other Income / Expenses(1.64M)(3.88M)71.86M39.11M9M
Income Before Tax(75.21M)52.55M48.23M151.69M263.3M
Pre-Tax Margin-0.8%0.5%0.4%1.3%2.1%
Income Tax Expense02.65M8.65M(241.05M)40.5M
Net Income(75.21M)49.9M39.58M392.74M222.8M
Net Margin-0.8%0.5%0.4%3.3%1.8%
EPS (Basic)(0.18)0.120.090.930.53
EPS (Diluted)(0.18)0.120.090.910.52
Weighted Avg Shares417.22M422.33M429.46M421.35M414.1M
Weighted Avg Shares (Diluted)417.22M427.77M432.04M430.99M425.8M

Chewy, Inc.

NYSE:CHWY

Intrinsic Alpha fair value

Locked

Current Price

$20.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.